CVS Health Corp (CH:CVS)
NYSE:CVS
CVS Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Strong Cash GenerationConsistent, multi-billion dollar operating and free cash flow provides durable financial flexibility. FCF coverage of earnings and stable OCF enable ongoing investment in care delivery, debt reduction, dividend support and tech/AI programs, cushioning the company through profit-cycle volatility.
Vertically Integrated Scale And Diversified RevenueLarge, diversified footprint across PBM, health benefits, retail pharmacy and care delivery creates structural advantages: cross-selling, negotiated purchasing scale, and lower unit costs. Scale smooths revenue volatility and supports durable competitive positioning in payer-provider integration.
Aetna Margin Recovery And Operational WinsMaterial YOY improvement at Aetna and lower MBR reflect better underwriting, utilization management and prior-authorization efficiencies. Sustainable improvement in insurance margins strengthens the enterprise's earnings power and validates care-management investments over the medium term.
Bears Say
Compressed Profitability And Weakened ReturnsSignificant margin compression and falling ROE indicate the business is earning much less on its asset and equity base than historically. Persistently low returns constrain reinvestment, slow deleveraging capacity, and reduce the long-term ability to generate excess shareholder value absent structural margin recovery.
PBM Rebate Guarantees And Client Price PressureStructural shifts in rebate contracting and client price concessions compress PBM spreads, a core earnings source. Reduced ability to retain manufacturer economics increases revenue volatility and makes long-term PBM profitability more sensitive to contract terms and regulatory change.
Regulatory And State-level UncertaintyFragmented state actions and evolving federal rules introduce sustained compliance, reimbursement and access risks for pharmacy and PBM operations. Ongoing legal and policy shifts can raise costs, limit fee schedules, and structurally alter revenue drivers across retail and PBM channels over multiple quarters.
CVS Health News
CVS FAQ
What was CVS Health Corp’s price range in the past 12 months?
Currently, no data Available
What is CVS Health Corp’s market cap?
CVS Health Corp’s market cap is CHF105.18B.
When is CVS Health Corp’s upcoming earnings report date?
CVS Health Corp’s upcoming earnings report date is Aug 05, 2026 which is in 41 days.
How were CVS Health Corp’s earnings last quarter?
CVS Health Corp released its earnings results on May 06, 2026. The company reported $2.043 earnings per share for the quarter, beating the consensus estimate of $1.736 by $0.307.
Is CVS Health Corp overvalued?
According to Wall Street analysts CVS Health Corp’s price is currently Undervalued.
Does CVS Health Corp pay dividends?
CVS Health Corp does not currently pay dividends.
What is CVS Health Corp’s EPS estimate?
CVS Health Corp’s EPS estimate is 1.46.
How many shares outstanding does CVS Health Corp have?
Currently, no data Available
What happened to CVS Health Corp’s price movement after its last earnings report?
CVS Health Corp reported an EPS of $2.043 in its last earnings report, beating expectations of $1.736. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of CVS Health Corp?
Currently, no hedge funds are holding shares in CH:CVS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
CVS Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
CHF85.33 (― Downside)
CHF85.33 (― Downside)
Insider Transactions
Sold Shares
Worth CHF262.7M over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 83%
Bearish news 17%
Bearish news 17%
Technicals
SMA
Positive
20 days / 200 days
Momentum
56.25%
12-Months-Change
Fundamentals
Return on Equity
3.87%
Trailing 12-Months
Asset Growth
-1.02%
Trailing 12-Months
Company Description
CVS Health Corp
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.
CVS Company Deck
CVS Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a generally positive tone driven by clear top-line growth, strong cash generation, profit and EPS beats, an upward revision to full-year EPS guidance, meaningful improvement at Aetna (material AOI gain and operational efficiencies), and ongoing technology/AI initiatives (Health100). Offsetting risks include segment-level profit declines (Health Services and PCW), membership impacts from the Individual Exchange exit, continued elevated medical cost trends, PBM rebate pressures and regulatory/state-level uncertainty. On balance, the favorable operating metrics, raised guidance, and credible path to margin recovery outweighed the identifiable challenges.View all CH:CVS earnings summariesCVS Revenue Breakdown
46.57% Health Services
35.05% Health Care Benefits
33.40% Pharmacy & Consumer Wellness
0.12% Corporate/ Other
CVS Stock 12 Month Forecast
Average Price Target
$85.33
Options Prices
Currently, No data available
---